ADCY8 and type 2 diabetes mellitus: The results of the current study corroborated this hypothesis and our earlier observations in T2D animals by finding similarly significantly enhanced levels of both ADCY8 and its functional secondary messenger, cAMP, in plasma from patients with T2D compared with ND controls.